| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.11% | 59.50% | 58.74% | 60.21% | 60.95% | 55.98% | 55.74% | 55.83% | 55.61% | 55.29% | 52.34% | 52.44% |
| Operating Margin | 19.09% | 20.37% | 21.77% | 27.61% | 25.35% | 18.99% | 18.25% | 17.11% | 16.48% | 16.29% | 16.87% | 17.23% |
| EBITDA Margin | 22.14% | 23.39% | 30.84% | 34.67% | 32.71% | 26.95% | 24.89% | 23.68% | 23.24% | 22.98% | 21.98% | 21.94% |
| Net Margin | 14.71% | 16.33% | 19.94% | 22.91% | 21.84% | 16.36% | 16.80% | 13.33% | 13.60% | 15.13% | 16.33% | 13.05% |
| Current Ratio | 1.87 | 1.40 | 1.68 | 1.89 | 1.43 | 1.86 | 5.19 | 1.47 | 1.43 | 0.97 | 1.27 | 1.75 |
| Quick Ratio | 1.51 | 1.05 | 1.37 | 1.52 | 1.09 | 1.55 | 4.86 | 1.07 | 1.05 | 0.72 | 0.93 | 1.41 |
| Debt / Equity | 0.35 | 0.32 | 0.34 | 0.39 | 0.49 | 0.53 | 0.72 | 0.35 | 0.40 | 0.53 | 0.54 | 0.15 |
| ROE | 6.88% | 7.87% | 8.91% | 14.39% | 14.24% | 9.17% | 9.93% | 9.39% | 9.45% | 11.07% | 14.13% | 11.08% |
| ROA | 4.33% | 5.03% | 5.64% | 8.55% | 7.73% | 4.79% | 4.85% | 5.54% | 5.34% | 5.64% | 6.96% | 7.02% |
| Asset Turnover | 0.29 | 0.31 | 0.28 | 0.37 | 0.35 | 0.29 | 0.29 | 0.42 | 0.39 | 0.37 | 0.43 | 0.54 |
| Book Value / Share | 73.37 | 67.21 | 71.98 | 67.96 | 61.32 | 55.35 | 41.74 | 39.74 | 37.34 | 32.98 | 33.54 | 32.75 |
Danaher Corporation is a leading science and technology company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. It operates primarily through three key segments: Biotechnology, which provides tools and services for bioprocessing, genomics, and proteomics; Life Sciences, offering advanced instrumentation for research in microscopy, flow cytometry, and mass spectrometry; and Diagnostics, delivering clinical instruments, software, and consumables for laboratory diagnostics, pathology, and healthcare settings. Danaher Corporation's portfolio includes diagnostic equipment, digital imaging systems, optical instruments, microscopes, water quality control systems, and disinfection solutions, serving healthcare providers, research institutions, pharmaceutical companies, and industrial clients. These offerings support critical applications in drug discovery, disease diagnosis, environmental monitoring, and quality assurance across global markets. Founded in 1984 and headquartered in Washington, District of Columbia, Danaher Corporation plays a vital role in advancing scientific innovation and improving health outcomes through its integrated solutions.